Compass Minerals Reports Fiscal Fourth-Quarter and Full-Year 2024 Results
Company Provides Financial Outlook for Fiscal Full-Year 2025
MANAGEMENT COMMENTARY
“There is no doubt that 2024 was a transitional year for our company. We made the important strategic decision to get 'back to basics' by refocusing on our core Salt and Plant Nutrition businesses. We made leadership and organizational changes throughout the year to support this effort. Our company also had to confront the challenges resulting from one of the mildest winters in the last quarter century, as well as headwinds from the termination of our lithium project and setbacks in the Fortress business. Against this backdrop, we undertook significant heavy lifting throughout the year to reorient the company on a path toward improved performance," said Edward C. Dowling Jr., president and CEO. "We still have work ahead of us, but we have a clear vision of what we need to do to optimize our unique and advantaged assets. We strongly believe that our focus on improving the cash generation capability across our platform and reducing our absolute levels of indebtedness will enable the creation of meaningful, long-term shareholder value."
FISCAL FOURTH-QUARTER AND FULL-YEAR 2024 SUMMARY
-
Net loss for the fourth quarter of 2024 of
, inclusive of a$48.3 million write down of certain intangible water rights in$17.6 million Utah ; -
Total company adjusted EBITDA for the fourth quarter of 2024 of
, down from$15.6 million in the prior year;$31.3 million -
Reported net loss of
for fiscal 2024 driven by significant non-cash impairments totaling$206.1 million in Lithium, Fire Retardant and Plant Nutrition businesses;$191.0 million -
Total company adjusted EBITDA up
4% year over year to ;$206.3 million -
Improved annual adjusted EBITDA per ton for Salt business by
20% to approximately despite$24.50 18% decline in Salt sales volumes; and -
Annual Plant Nutrition sales volumes increased
25% in 2024 to 273 thousand tons.
2024 FINANCIAL RESULTS
(in millions, except per share data) |
|
Three Months Ended Sept. 30, 2024 |
|
Fiscal Year Ended Sept. 30, 2024 |
||||
Revenue |
|
$ |
208.8 |
|
|
$ |
1,117.4 |
|
Operating loss |
|
|
(29.8 |
) |
|
|
(116.8 |
) |
Adjusted operating (loss) earnings* |
|
|
(12.8 |
) |
|
|
93.2 |
|
Adjusted EBITDA* |
|
|
15.6 |
|
|
|
206.3 |
|
Net loss |
|
|
(48.3 |
) |
|
|
(206.1 |
) |
Net (loss) earnings per diluted share |
|
|
(1.17 |
) |
|
|
(4.99 |
) |
Adjusted net (loss) earnings* |
|
|
(31.5 |
) |
|
|
3.7 |
|
Adjusted net (loss) earnings* per diluted share |
|
$ |
(0.77 |
) |
|
$ |
0.08 |
|
* Non-GAAP financial measure. Reconciliations to the most directly comparable GAAP financial measure are provided in tables at the end of this press release.
SALT BUSINESS SUMMARY
Salt segment fiscal 2024 fourth-quarter revenue totaled
For the fiscal full-year 2024, Salt segment revenue was down
PLANT NUTRITION BUSINESS SUMMARY
Plant Nutrition segment fourth-quarter revenue totaled
For the fourth quarter, distribution costs per ton decreased
For the full fiscal year, the segment grew revenue
FIRE RETARDANT BUSINESS UPDATE
Compass Minerals continues to evaluate various alternatives regarding the path forward for Fortress North America (Fortress). Discussions are ongoing with the
CASH FLOW AND FINANCIAL POSITION
Net cash provided by operating activities amounted to
Net cash used in investing activities was
Net cash provided by financing activities was
The company ended the fiscal year with
FISCAL 2025 OUTLOOK
-
Salt sales volumes for 2025 at the midpoint of guidance are expected to increase approximately
9% over 2024, assuming average sales-to-commitment ratios; -
Completed 2024-2025 bid season resulted in North American highway deicing prices down approximately
2% and committed volumes down roughly9% ; and - Plant Nutrition earnings expected to be in line with 2024 levels while efforts continue to restore the business, driven by lower SOP pricing offset by improving volumes and lower forecasted production costs.
Salt Segment Range of Outcomes |
|
|
2025 Range1 |
Highway deicing sales volumes (thousands of tons) |
7,800 - 8,700 |
Consumer and industrial sales volumes (thousands of tons) |
1,850 - 2,000 |
Total salt sales volumes (thousands of tons) |
9,650 - 10,700 |
|
|
Revenue (in millions) |
|
Adj. EBITDA (in millions) |
|
(1) | Range for fiscal 2025 reflects the company's committed book of business for the period and assumes an average historical sales-to-commitment outcomes. |
Consistent with the results disclosed in the company's third-quarter fiscal 2024 results, the average contract price for the upcoming North American winter season is expected to be approximately
While demand for deicing salt is stable over time, the nature of winter weather and the manner in which customers respond to weather events make forecasting deicing sales volumes difficult during any single year. Therefore, the company has provided a guidance range that is informed by a historical average of sales to commitment ratios.
Compass Minerals expects that approximately
The company will continue to focus in fiscal 2025 on reducing Salt segment inventory across the platform and then align production levels with anticipated demand based on the results of North American highway deicing season.
Plant Nutrition Segment Guidance |
|
|
2025 Range |
Sales volumes (thousands of tons) |
285 - 305 |
Revenue (in millions) |
|
Adj. EBITDA (in millions) |
|
The company expects a modest increase in sales volumes in 2025 as economic conditions in certain key markets are anticipated to improve. SOP prices are expected to decline year over year as a result of anticipated weakness in global potash prices. Operationally, the focus of the Plant Nutrition segment in 2025 is on the restoration of the company's
Corporate |
|
|
2025 Range |
|
Total1 |
Adj. EBITDA (in millions) |
( |
(1) |
Includes |
Projected Corporate segment results shown in the table above include corporate expenses in support of our core businesses, Fortress financial results, and the results of DeepStore, the company's records and management services business in the
Total Compass Minerals |
||||
|
2025 Adjusted EBITDA |
|||
|
Salt |
Plant Nutrition |
Corporate1 |
Total |
Adj. EBITDA (in millions) |
|
|
( |
|
|
|
|
|
|
|
2025 Capital Expenditures |
|||
|
|
|
|
Total |
Capital expenditures (in millions) |
|
|
|
|
(1) | Includes financial contribution from DeepStore and Fortress. |
Total capital expenditures for the company in fiscal 2025 are expected to be within a range of
Other Assumptions |
|
($ in millions) |
2025 Range |
Depreciation, depletion and amortization |
|
Interest expense, net |
|
Effective income tax rate (excl. valuation allowance) |
( |
The guidance for the 2025 effective income tax rate reflects the income mix by country with income recognized in foreign jurisdictions offset by losses recognized in the
CONFERENCE CALL
Compass Minerals will discuss its results on a conference call tomorrow morning, Tuesday, Dec. 17, at 10:00 a.m. ET. To access the conference call, please visit the company’s website at investors.compassminerals.com or dial 800-715-9871. Callers must provide the conference ID number 7896827. Outside of the
A corporate presentation with fiscal 2024 results is available at investors.compassminerals.com.
About Compass Minerals
Compass Minerals (NYSE: CMP) is a leading global provider of essential minerals focused on safely delivering where and when it matters to help solve nature’s challenges for customers and communities. The company’s salt products help keep roadways safe during winter weather and are used in numerous other consumer, industrial, chemical and agricultural applications. Its plant nutrition products help improve the quality and yield of crops, while supporting sustainable agriculture. Additionally, it is working to develop a long-term fire-retardant business. Compass Minerals operates 12 production and packaging facilities with nearly 2,000 employees throughout the
Forward-Looking Statements and Other Disclaimers
This press release may contain forward-looking statements, including, without limitation, statements about cash generation capability; debt reduction; value creation; expectations for Fortress; the company's outlook for 2025, including its expectations regarding pricing, sales volumes, revenue, corporate and other expense, depreciation, depletion and amortization, interest expense, tax rates, capital expenditures, operating expenses, and Adjusted EBITDA. Forward-looking statements are those that predict or describe future events or trends and that do not relate solely to historical matters. We use words such as “may,” “would,” “could,” “should,” “will,” “likely,” “expect,” “anticipate,” “believe,” “intend,” “plan,” “forecast,” “outlook,” “project,” “estimate” and similar expressions suggesting future outcomes or events to identify forward-looking statements or forward-looking information. These statements are based on the company’s current expectations and involve risks and uncertainties that could cause the company’s actual results to differ materially. The differences could be caused by a number of factors, including without limitation (i) weather conditions, (ii) inflation, the cost and availability of transportation for the distribution of the company’s products and foreign exchange rates, (iii) pressure on prices and impact from competitive products, (iv) any inability by the company to successfully implement its strategic priorities or its cost-saving or enterprise optimization initiatives, and (v) the risk that the company may not realize the intended financial or other benefits from, or that it may incur unexpected costs in connection with, its ownership of Fortress North America. For further information on these and other risks and uncertainties that may affect the company’s business, see the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the company’s Annual Report on Form 10-K for the period ended Sept. 30, 2024, its Amended Quarterly Reports on Form 10-Q/A for the quarters ended Dec. 31, 2023 and Mar. 31, 2024, and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 filed or to be filed with the SEC, as well as the company's other SEC filings. The company undertakes no obligation to update any forward-looking statements made in this press release to reflect future events or developments, except as required by law. Because it is not possible to predict or identify all such factors, this list cannot be considered a complete set of all potential risks or uncertainties.
Non-GAAP Measures
In addition to using
Management uses EBITDA, EBITDA adjusted for items which management believes are not indicative of the company’s ongoing operating performance (“Adjusted EBITDA”) and EBITDA margin to evaluate the operating performance of the company’s core business operations because its resource allocation, financing methods and cost of capital, and income tax positions are managed at a corporate level, apart from the activities of the operating segments, and the operating facilities are located in different taxing jurisdictions, which can cause considerable variation in net earnings. Management also uses adjusted operating earnings, adjusted operating margin, adjusted net earnings, and adjusted net earnings per diluted share, which eliminate the impact of certain items that management does not consider indicative of underlying operating performance. The presentation of these measures should not be construed as an inference that future results will be unaffected by unusual or non-recurring items. Management believes these non-GAAP financial measures provide management and investors with additional information that is helpful when evaluating underlying performance. EBITDA and Adjusted EBITDA exclude interest expense, income taxes and depreciation, depletion and amortization, each of which are an essential element of the company’s cost structure and cannot be eliminated. In addition, Adjusted EBITDA and Adjusted EBITDA margin exclude certain cash and non-cash items, including stock-based compensation. Consequently, any measure that excludes these elements has material limitations. The non-GAAP financial measures used by management should not be considered in isolation or as a substitute for net earnings, operating earnings, cash flows or other financial data prepared in accordance with GAAP or as a measure of overall profitability or liquidity. These measures are not necessarily comparable to similarly titled measures of other companies due to potential inconsistencies in the method of calculation. The calculation of non-GAAP financial measures as used by management is set forth in the following tables. All margin numbers are defined as the relevant measure divided by sales. The company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. The amounts and timing of these items are uncertain and could be material to the company’s results.
Adjusted operating earnings, adjusted operating earnings margin, adjusted net (loss) earnings, and adjusted net (loss) earnings per diluted share are presented as supplemental measures of the company’s performance. Management believes these measures provide management and investors with additional information that is helpful when evaluating underlying performance and comparing results on a year-over-year normalized basis. These measures eliminate the impact of certain items that management does not consider indicative of underlying operating performance. These adjustments are itemized below. Adjusted net (loss) earnings per diluted share is adjusted net (loss) earnings divided by weighted average diluted shares outstanding. You are encouraged to evaluate the adjustments itemized above and the reasons management considers them appropriate for supplemental analysis. In evaluating these measures you should be aware that in the future the company may incur expenses that are the same as or similar to some of the adjustments presented below.
Special Items Impacting the Three Months Ended Sept. 30, 2024 (unaudited, in millions, except per share data) |
||||||||||||||||||||
Item Description |
|
Segment |
|
Line Item |
|
Amount |
|
Tax Effect(1) |
|
After Tax |
|
EPS Impact |
||||||||
Restructuring charges(2) |
|
Corporate and Other |
|
Other operating expense |
|
$ |
(1.4 |
) |
|
$ |
— |
|
|
$ |
(1.4 |
) |
|
$ |
(0.04 |
) |
Impairments |
|
Plant Nutrition |
|
Loss on impairments |
|
|
17.6 |
|
|
|
— |
|
|
|
17.6 |
|
|
|
0.43 |
|
Provision for product recall costs |
|
Salt |
|
Other operating expense |
|
|
0.8 |
|
|
|
(0.2 |
) |
|
|
0.6 |
|
|
|
0.01 |
|
Total |
|
|
|
|
|
$ |
17.0 |
|
|
$ |
(0.2 |
) |
|
$ |
16.8 |
|
|
$ |
0.40 |
|
Special Items Impacting the Three Months Ended Sept. 30, 2023 (unaudited, in millions, except per share data) |
||||||||||||||||||||
Item Description |
|
Segment |
|
Line Item |
|
Amount |
|
Tax Effect(1) |
|
After Tax |
|
EPS Impact |
||||||||
Accrued legal costs related to SEC investigation |
|
Corporate and Other |
|
Other operating expense |
|
$ |
(0.2 |
) |
|
$ |
— |
|
$ |
(0.2 |
) |
|
$ |
— |
Special Items Impacting the Fiscal Year Ended Sept. 30, 2024 (unaudited, in millions, except per share data) |
||||||||||||||||||||
Item Description |
|
Segment |
|
Line Item |
|
Amount |
|
Tax Effect(1) |
|
After Tax |
|
EPS Impact |
||||||||
Restructuring charges(2) |
|
Corporate and Other |
|
Other operating expense |
|
$ |
14.8 |
|
$ |
— |
|
|
$ |
14.8 |
|
$ |
0.36 |
|||
Restructuring charges(2) |
|
Salt |
|
Other operating expense |
|
|
0.4 |
|
|
— |
|
|
|
0.4 |
|
|
0.01 |
|||
Restructuring charges(2) |
|
Plant Nutrition |
|
Other operating expense |
|
|
0.6 |
|
|
— |
|
|
|
0.6 |
|
|
0.01 |
|||
Impairments |
|
Corporate and Other |
|
COGS and Loss on impairments |
|
|
124.8 |
|
|
|
|
124.8 |
|
|
3.02 |
|||||
Impairments |
|
Plant Nutrition |
|
Loss on impairments |
|
|
68.6 |
|
|
— |
|
|
|
68.6 |
|
|
1.66 |
|||
Provision for product recall costs |
|
Salt |
|
Other operating expense |
|
|
0.8 |
|
|
(0.2 |
) |
|
|
0.6 |
|
|
0.01 |
|||
Total |
|
|
|
|
|
$ |
210.0 |
|
$ |
(0.2 |
) |
|
$ |
209.8 |
|
$ |
5.07 |
Special Items Impacting the Fiscal Year Ended Sept. 30, 2023 (unaudited, in millions, except per share data) |
||||||||||||||||||||
Item Description |
|
Segment |
|
Line Item |
|
Amount |
|
Tax Effect(1) |
|
After Tax |
|
EPS Impact |
||||||||
Restructuring charges |
|
Corporate and Other |
|
Other operating expense |
|
$ |
2.6 |
|
|
$ |
— |
|
|
$ |
2.6 |
|
|
$ |
0.07 |
|
Restructuring charges |
|
Salt |
|
COGS and other operating expense |
|
|
1.5 |
|
|
|
(0.1 |
) |
|
|
1.4 |
|
|
|
0.04 |
|
Restructuring charges |
|
Plant Nutrition |
|
COGS and other operating expense |
|
|
1.4 |
|
|
|
— |
|
|
|
1.4 |
|
|
|
0.03 |
|
Accrued legal costs related to SEC investigation |
|
Corporate and Other |
|
Other operating expense |
|
|
(0.3 |
) |
|
|
— |
|
|
|
(0.3 |
) |
|
|
(0.01 |
) |
Total |
|
|
|
|
|
$ |
5.2 |
|
|
$ |
(0.1 |
) |
|
$ |
5.1 |
|
|
$ |
0.13 |
|
(1) |
There were no substantial income tax benefits related to these items given the |
(2) |
Restructuring charges do not include certain reductions in stock-based compensation associated with forfeitures stemming from the restructuring activities. Amounts in the quarter ended Sept. 30, 2024, reflect the reversal of certain previously recognized costs related to the terminated lithium program after outstanding purchase commitments were finalized. |
Reconciliation for Adjusted Operating (Loss) Earnings (unaudited, in millions) |
|||||||||||||||
|
Three months ended Sept. 30, |
|
Twelve months ended Sept. 30, |
||||||||||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||
Operating (loss) earnings |
$ |
(29.8 |
) |
|
$ |
2.2 |
|
|
$ |
(116.8 |
) |
|
$ |
77.4 |
|
Restructuring charges(1) |
|
(1.4 |
) |
|
|
— |
|
. |
|
15.8 |
|
|
|
5.5 |
|
Loss on impairments(2) |
|
17.6 |
|
|
|
— |
|
. |
|
193.4 |
|
|
|
— |
|
Provision for product recall costs(3) |
|
0.8 |
|
|
|
— |
|
. |
|
0.8 |
|
|
|
— |
|
Accrued loss and legal costs related to SEC investigation(4) |
|
— |
|
|
|
(0.2 |
) |
. |
|
— |
|
|
|
(0.3 |
) |
Adjusted operating (loss) earnings |
$ |
(12.8 |
) |
|
$ |
2.0 |
|
. |
$ |
93.2 |
|
|
$ |
82.6 |
|
Sales |
|
208.8 |
|
|
|
233.6 |
|
. |
|
1,117.4 |
|
|
|
1,204.7 |
|
Operating margin |
|
(14.3 |
)% |
|
|
0.9 |
% |
. |
|
(10.5 |
)% |
|
|
6.4 |
% |
Adjusted operating margin |
|
(6.1 |
)% |
|
|
0.9 |
% |
. |
|
8.3 |
% |
|
|
6.9 |
% |
(1) |
The company incurred severance and related charges for reductions in workforce, changes to executive leadership and additional restructuring costs related to the termination of the Company’s lithium development project. |
(2) |
The company recognized impairments of long-lived assets related to the termination of the lithium development project; goodwill, long-lived assets and inventory related to Fortress; goodwill related to Plant Nutrition; and water rights for the fiscal year ended Sept. 30, 2024. Impairments of long-lived assets and goodwill are included in loss on impairments, while the impairment of inventory is included in product cost, both on the Consolidated Statements of Operations. |
(3) |
The company recorded a provision for potential costs related to a recall for food-grade salt produced at its Goderich Plant. |
(4) |
The company recognized reimbursements related to the settled SEC investigation. |
Reconciliation for Adjusted Net (Loss) Earnings (unaudited, in millions) |
|||||||||||||||
|
Three months ended Sept. 30, |
|
Twelve months ended Sept. 30, |
||||||||||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||
Net (loss) earnings |
$ |
(48.3 |
) |
|
$ |
(4.0 |
) |
|
$ |
(206.1 |
) |
|
$ |
10.5 |
|
Restructuring charges(1) |
|
(1.4 |
) |
|
|
— |
|
|
15.8 |
|
|
|
5.5 |
|
|
Loss on impairments(2) |
|
17.6 |
|
|
|
— |
|
|
193.4 |
|
|
|
— |
|
|
Provision for product recall costs(3) |
|
0.8 |
|
|
|
— |
|
|
0.8 |
|
|
|
— |
|
|
Accrued loss and legal costs related to SEC investigation(4) |
|
— |
|
|
|
(0.2 |
) |
|
— |
|
|
|
(0.3 |
) |
|
Income tax effect |
|
(0.2 |
) |
|
|
— |
|
|
(0.2 |
) |
|
|
(0.1 |
) |
|
Adjusted net (loss) earnings |
$ |
(31.5 |
) |
|
$ |
(4.2 |
) |
$ |
3.7 |
|
|
$ |
15.6 |
|
|
|
|
|
|
|
|
|
|
||||||||
Diluted net (loss) earnings per common share |
$ |
(1.17 |
) |
|
$ |
(0.10 |
) |
|
$ |
(4.99 |
) |
|
$ |
0.25 |
|
Adjusted net (loss) earnings per diluted share |
$ |
(0.77 |
) |
|
$ |
(0.10 |
) |
$ |
0.08 |
|
|
$ |
0.38 |
|
|
Weighted-average common shares outstanding (in thousands): |
|
|
|
|
|
|
|
||||||||
Diluted |
|
41,369 |
|
|
|
41,152 |
|
|
|
41,306 |
|
|
|
40,786 |
|
(1) |
The company incurred severance and related charges related to reductions in workforce, changes to executive leadership and additional restructuring costs related to the termination of our lithium development project. Charges for the twelve months ended Sept. 30, 2023 were |
(2) |
The company recognized impairments of water rights for the three months ended Sept. 30, 2024. The company also recognized impairments of long-lived assets related to the termination of the lithium development project; goodwill, long-lived assets and inventory related to Fortress; and goodwill related to Plant Nutrition for the twelve months ended Sept. 30, 2024. |
(3) |
The company recorded a provision for potential costs related to a recall for food-grade salt produced at its Goderich Plant. Charges for the three and twelve months ended Sept. 30, 2024 were |
(4) |
The company recognized reimbursements related to the settled SEC investigation. |
Reconciliation for EBITDA and Adjusted EBITDA (unaudited, in millions) |
|||||||||||||||
|
Three months ended Sept. 30, |
|
Twelve months ended Sept. 30, |
||||||||||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
||||||||
Net (loss) earnings |
$ |
(48.3 |
) |
|
$ |
(4.0 |
) |
|
$ |
(206.1 |
) |
|
$ |
10.5 |
|
Interest expense |
|
19.1 |
|
|
|
13.1 |
|
|
|
69.5 |
|
|
|
55.5 |
|
Income tax (benefit) expense |
|
(2.5 |
) |
|
|
(7.1 |
) |
|
|
17.9 |
|
|
|
17.1 |
|
Depreciation, depletion and amortization |
|
26.6 |
|
|
|
25.9 |
|
|
|
105.0 |
|
|
|
98.6 |
|
EBITDA |
|
(5.1 |
) |
|
|
27.9 |
|
|
|
(13.7 |
) |
|
|
181.7 |
|
Adjustments to EBITDA |
|
|
|
|
|
|
|
||||||||
Stock-based compensation - non cash |
|
1.8 |
|
|
|
3.4 |
|
|
|
8.1 |
|
|
|
20.6 |
|
Interest income |
|
(0.2 |
) |
|
|
(0.6 |
) |
|
|
(1.0 |
) |
|
|
(5.3 |
) |
Loss (gain) on foreign exchange |
|
1.8 |
|
|
|
(2.3 |
) |
|
|
0.7 |
|
|
|
2.3 |
|
Loss (gain) from remeasurement of equity method investment |
|
— |
|
|
|
2.5 |
|
|
|
— |
|
|
|
(10.1 |
) |
Restructuring charges(1) |
|
(1.4 |
) |
|
|
— |
|
|
|
15.8 |
|
|
|
5.9 |
|
Loss on impairments(2) |
|
17.6 |
|
|
|
— |
|
|
|
193.4 |
|
|
|
— |
|
Provision for product recall costs(3) |
|
0.8 |
|
|
|
— |
|
|
|
0.8 |
|
|
|
— |
|
Accrued loss and legal costs related to SEC investigation(4) |
|
— |
|
|
|
(0.2 |
) |
|
|
— |
|
|
|
(0.3 |
) |
Other, net |
|
0.3 |
|
|
|
0.6 |
|
|
|
2.2 |
|
|
|
4.3 |
|
Adjusted EBITDA |
|
15.6 |
|
|
|
31.3 |
|
|
|
206.3 |
|
|
|
199.1 |
|
(1) |
The company incurred severance and related charges related to a reduction of its workforce, changes to executive leadership and additional restructuring costs related to the termination of our lithium development project. |
(2) |
The company recognized impairments of water rights for the three months ended Sept. 30, 2024. The company also recognized impairments of long-lived assets related to the termination of the lithium development project; goodwill, long-lived assets and inventory related to Fortress; and goodwill related to Plant Nutrition for the twelve months ended Sept. 30, 2024. |
(3) |
The company recorded a provision for potential costs related to a recall for food-grade salt produced at its Goderich Plant. |
(4) |
The company recognized reimbursements related to the settled SEC investigation. |
Salt Segment Performance
|
|||||||||||||||
|
Three months ended Sept. 30, |
|
Twelve months ended Sept. 30, |
||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Sales |
$ |
162.5 |
|
|
$ |
186.7 |
|
|
$ |
907.8 |
|
|
$ |
1,010.8 |
|
Operating earnings |
$ |
21.0 |
|
|
$ |
28.6 |
|
|
$ |
163.6 |
|
|
$ |
170.5 |
|
Operating margin |
|
12.9 |
% |
|
|
15.3 |
% |
|
|
18.0 |
% |
|
|
16.9 |
% |
Adjusted operating earnings(1) |
$ |
21.8 |
|
|
$ |
28.6 |
|
|
$ |
164.8 |
|
|
$ |
172.0 |
|
Adjusted operating margin(1) |
|
13.4 |
% |
|
|
15.3 |
% |
|
|
18.2 |
% |
|
|
17.0 |
% |
EBITDA(1) |
$ |
37.3 |
|
|
$ |
44.2 |
|
|
$ |
227.0 |
|
|
$ |
229.0 |
|
EBITDA(1) margin |
|
23.0 |
% |
|
|
23.7 |
% |
|
|
25.0 |
% |
|
|
22.7 |
% |
Adjusted EBITDA(1) |
$ |
38.1 |
|
|
$ |
44.2 |
|
|
$ |
228.2 |
|
|
$ |
230.5 |
|
Adjusted EBITDA(1) margin |
|
23.4 |
% |
|
|
23.7 |
% |
|
|
25.1 |
% |
|
|
22.8 |
% |
Sales volumes (in thousands of tons): |
|
|
|
|
|
|
|
||||||||
Highway deicing |
|
1,061 |
|
|
|
1,435 |
|
|
|
7,462 |
|
|
|
9,321 |
|
Consumer and industrial |
|
449 |
|
|
|
470 |
|
|
|
1,852 |
|
|
|
1,999 |
|
Total Salt |
|
1,510 |
|
|
|
1,905 |
|
|
|
9,314 |
|
|
|
11,320 |
|
Average sales prices (per ton): |
|
|
|
|
|
|
|
||||||||
Highway deicing |
$ |
70.98 |
|
|
$ |
68.78 |
|
|
$ |
73.23 |
|
|
$ |
68.85 |
|
Consumer and industrial |
$ |
194.41 |
|
|
$ |
187.44 |
|
|
$ |
195.14 |
|
|
$ |
184.67 |
|
Total Salt |
$ |
107.66 |
|
|
$ |
98.03 |
|
|
$ |
97.47 |
|
|
$ |
89.29 |
(1) | Non-GAAP financial measure. Reconciliations follow in these tables. |
Reconciliation for Salt Segment Adjusted Operating Earnings (unaudited, in millions) |
|||||||||||||||
|
Three months ended Sept. 30, |
|
Twelve months ended Sept. 30, |
||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Reported GAAP segment operating earnings |
$ |
21.0 |
|
|
$ |
28.6 |
|
|
$ |
163.6 |
|
|
$ |
170.5 |
|
Restructuring charges(1) |
|
— |
|
|
|
— |
|
. |
|
0.4 |
|
|
|
1.5 |
|
Provision for product recall costs(2) |
|
0.8 |
|
|
|
— |
|
. |
|
0.8 |
|
|
|
— |
|
Segment adjusted operating earnings |
$ |
21.8 |
|
|
$ |
28.6 |
|
|
$ |
164.8 |
|
|
$ |
172.0 |
|
Segment sales |
|
162.5 |
|
|
|
186.7 |
|
. |
|
907.8 |
|
|
|
1,010.8 |
|
Segment adjusted operating margin |
|
13.4 |
% |
|
|
15.3 |
% |
|
|
18.2 |
% |
|
|
17.0 |
% |
(1) | The company incurred severance and related charges related to a reduction of its workforce. |
(2) | The company recorded a provision for potential costs related to a recall for food-grade salt produced at its Goderich Plant. |
Reconciliation for Salt Segment EBITDA and Adjusted EBITDA (unaudited, in millions) |
|||||||||||||||
|
Three months ended Sept. 30, |
|
Twelve months ended Sept. 30, |
||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Reported GAAP segment operating earnings |
$ |
21.0 |
|
|
$ |
28.6 |
|
|
$ |
163.6 |
|
|
$ |
170.5 |
|
Depreciation, depletion and amortization |
|
16.3 |
|
|
|
15.6 |
|
|
|
63.4 |
|
|
|
58.5 |
|
Segment EBITDA |
$ |
37.3 |
|
|
$ |
44.2 |
|
|
$ |
227.0 |
|
|
$ |
229.0 |
|
Restructuring charges(1) |
|
— |
|
|
|
— |
|
|
|
0.4 |
|
|
|
1.5 |
|
Provision for product recall costs(2) |
|
0.8 |
|
|
|
— |
|
|
|
0.8 |
|
|
|
— |
|
Segment adjusted EBITDA |
$ |
38.1 |
|
|
$ |
44.2 |
|
|
$ |
228.2 |
|
|
$ |
230.5 |
|
Segment sales |
|
162.5 |
|
|
|
186.7 |
|
|
|
907.8 |
|
|
|
1,010.8 |
|
Segment adjusted EBITDA margin |
|
23.4 |
% |
|
|
23.7 |
% |
|
|
25.1 |
% |
|
|
22.8 |
% |
(1) | The company incurred severance and related charges related to a reduction of its workforce. |
(2) | The company recorded a provision for potential costs related to a recall for food-grade salt produced at its Goderich Plant. |
Plant Nutrition Segment Performance (in millions, except for prices per short ton) |
|||||||||||||||
|
Three months ended Sept. 30, |
|
Twelve months ended Sept. 30, |
||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Sales |
$ |
42.4 |
|
|
$ |
35.3 |
|
|
$ |
181.0 |
|
|
$ |
172.1 |
|
Operating (loss) earnings |
$ |
(29.7 |
) |
|
$ |
(3.3 |
) |
|
$ |
(86.4 |
) |
|
$ |
9.5 |
|
Operating margin |
|
(70.0 |
)% |
|
|
(9.3 |
)% |
|
|
(47.7 |
)% |
|
|
5.5 |
% |
Adjusted operating (loss) earnings(1) |
$ |
(12.1 |
) |
|
$ |
(3.3 |
) |
|
$ |
(17.2 |
) |
|
$ |
10.9 |
|
Adjusted operating margin(1) |
|
(28.5 |
)% |
|
|
(9.3 |
)% |
|
|
(9.5 |
)% |
|
|
6.3 |
% |
EBITDA(1) |
$ |
(21.3 |
) |
|
$ |
5.0 |
|
|
$ |
(52.3 |
) |
|
$ |
42.4 |
|
EBITDA(1) margin |
|
(50.2 |
)% |
|
|
14.2 |
% |
|
|
(28.9 |
)% |
|
|
24.6 |
% |
Adjusted EBITDA(1) |
$ |
(3.7 |
) |
|
$ |
5.0 |
|
|
$ |
16.9 |
|
|
$ |
43.8 |
|
Adjusted EBITDA(1) margin |
|
(8.7 |
)% |
|
|
14.2 |
% |
|
|
9.3 |
% |
|
|
25.5 |
% |
Sales volumes (in thousands of tons) |
|
68 |
|
|
|
51 |
|
|
|
273 |
|
|
|
219 |
|
Average sales price (per ton) |
$ |
623 |
|
|
$ |
691 |
|
|
$ |
663 |
|
|
$ |
785 |
(1) | Non-GAAP financial measure. Reconciliations follow in these tables. |
Reconciliation for Plant Nutrition Segment Adjusted Operating Earnings (unaudited, in millions) |
|||||||||||||||
|
Three months ended Sept. 30, |
|
Twelve months ended Sept. 30, |
||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Reported GAAP segment operating (loss) earnings |
$ |
(29.7 |
) |
|
$ |
(3.3 |
) |
|
$ |
(86.4 |
) |
|
$ |
9.5 |
|
Restructuring charges(1) |
|
— |
|
|
|
— |
|
. |
|
0.6 |
|
|
|
1.4 |
|
Loss on impairment(2) |
|
17.6 |
|
|
|
— |
|
. |
|
68.6 |
|
|
|
— |
|
Segment adjusted operating (loss) earnings |
$ |
(12.1 |
) |
|
$ |
(3.3 |
) |
|
$ |
(17.2 |
) |
|
$ |
10.9 |
|
Segment sales |
|
42.4 |
|
|
|
35.3 |
|
. |
|
181.0 |
|
|
|
172.1 |
|
Segment adjusted operating margin |
|
(28.5 |
)% |
|
|
(9.3 |
)% |
|
|
(9.5 |
)% |
|
|
6.3 |
% |
(1) | The company incurred severance and related charges related to a reduction of its workforce. |
(2) | The company recognized a water rights impairment during the three months ended Sept. 30, 2024 and goodwill impairment during the twelve months ended Sept. 30, 2024. |
Reconciliation for Plant Nutrition Segment EBITDA and Adjusted EBITDA (unaudited, in millions) |
|||||||||||||||
|
Three months ended Sept. 30, |
|
Twelve months ended Sept. 30, |
||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Reported GAAP segment operating (loss) earnings |
$ |
(29.7 |
) |
|
$ |
(3.3 |
) |
|
$ |
(86.4 |
) |
|
$ |
9.5 |
|
Depreciation, depletion and amortization |
|
8.4 |
|
|
|
8.3 |
|
|
|
34.1 |
|
|
|
32.9 |
|
Segment EBITDA |
$ |
(21.3 |
) |
|
$ |
5.0 |
|
|
$ |
(52.3 |
) |
|
$ |
42.4 |
|
Restructuring charges(1) |
|
— |
|
|
|
— |
|
|
|
0.6 |
|
|
|
1.4 |
|
Loss on impairment(2) |
|
17.6 |
|
|
|
— |
|
|
|
68.6 |
|
|
|
— |
|
Segment Adjusted EBITDA |
$ |
(3.7 |
) |
|
$ |
5.0 |
|
|
$ |
16.9 |
|
|
$ |
43.8 |
|
Segment sales |
|
42.4 |
|
|
|
35.3 |
|
|
|
181.0 |
|
|
|
172.1 |
|
Segment adjusted EBITDA margin |
|
(8.7 |
)% |
|
|
14.2 |
% |
|
|
9.3 |
% |
|
|
25.5 |
% |
(1) | The company incurred severance and related charges related to a reduction of its workforce. |
(2) | The company recognized a water rights impairment during the three months ended Sept. 30, 2024 and goodwill impairment during the twelve months ended Sept. 30, 2024. |
COMPASS MINERALS INTERNATIONAL, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited, in millions, except share and per-share data) |
|||||||||||||||
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
Sept. 30, |
|
Sept. 30, |
||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Sales |
$ |
208.8 |
|
|
$ |
233.6 |
|
|
$ |
1,117.4 |
|
|
$ |
1,204.7 |
|
Shipping and handling cost |
|
50.2 |
|
|
|
54.8 |
|
|
|
305.3 |
|
|
|
346.1 |
|
Product cost |
|
139.1 |
|
|
|
136.6 |
|
|
|
617.1 |
|
|
|
626.6 |
|
Gross profit |
|
19.5 |
|
|
|
42.2 |
|
|
|
195.0 |
|
|
|
232.0 |
|
Selling, general and administrative expenses |
|
31.3 |
|
|
|
41.0 |
|
|
|
137.8 |
|
|
|
150.2 |
|
Loss on impairments |
|
17.6 |
|
|
|
— |
|
|
|
191.0 |
|
|
|
— |
|
Other operating expense (income) |
|
0.4 |
|
|
|
(1.0 |
) |
|
|
(17.0 |
) |
|
|
4.4 |
|
Operating (loss) earnings |
|
(29.8 |
) |
|
|
2.2 |
|
|
|
(116.8 |
) |
|
|
77.4 |
|
Other expense (income): |
|
|
|
|
|
|
|
||||||||
Interest income |
|
(0.2 |
) |
|
|
(0.6 |
) |
|
|
(1.0 |
) |
|
|
(5.3 |
) |
Interest expense |
|
19.1 |
|
|
|
13.1 |
|
|
|
69.5 |
|
|
|
55.5 |
|
Loss (gain) on foreign exchange |
|
1.8 |
|
|
|
(2.3 |
) |
|
|
0.7 |
|
|
|
2.3 |
|
Net loss in equity investees |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3.1 |
|
Loss (gain) from remeasurement of equity method investment |
|
— |
|
|
|
2.5 |
|
|
|
— |
|
|
|
(10.1 |
) |
Other expense, net |
|
0.3 |
|
|
|
0.6 |
|
|
|
2.2 |
|
|
|
4.3 |
|
Loss before income taxes |
|
(50.8 |
) |
|
|
(11.1 |
) |
|
|
(188.2 |
) |
|
|
27.6 |
|
Income tax (benefit) expense |
|
(2.5 |
) |
|
|
(7.1 |
) |
|
|
17.9 |
|
|
|
17.1 |
|
Net (loss) earnings |
$ |
(48.3 |
) |
|
$ |
(4.0 |
) |
|
$ |
(206.1 |
) |
|
$ |
10.5 |
|
|
|
|
|
|
|
|
|
||||||||
Basic net (loss) earnings per common share |
$ |
(1.17 |
) |
|
$ |
(0.10 |
) |
|
$ |
(4.99 |
) |
|
$ |
0.25 |
|
Diluted net (loss) earnings per common share |
$ |
(1.17 |
) |
|
$ |
(0.10 |
) |
|
$ |
(4.99 |
) |
|
$ |
0.25 |
|
|
|
|
|
|
|
|
|
||||||||
Cash dividends per share |
$ |
— |
|
|
$ |
0.15 |
|
|
$ |
0.30 |
|
|
$ |
0.60 |
|
Weighted-average common shares outstanding (in thousands):(1) |
|
|
|
|
|
|
|
||||||||
Basic |
|
41,369 |
|
|
|
41,152 |
|
|
|
41,306 |
|
|
|
40,786 |
|
Diluted |
|
41,369 |
|
|
|
41,152 |
|
|
|
41,306 |
|
|
|
40,786 |
|
(1) |
Excludes weighted participating securities such as RSUs and PSUs that receive non-forfeitable dividends, which consist of 578,000 and 667,000 weighted participating securities for the three and twelve months ended Sept. 30, 2024, respectively, and 495,000 and 476,000 weighted participating securities for the three and twelve months ended Sept. 30, 2023, respectively. |
COMPASS MINERALS INTERNATIONAL, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited, in millions) |
|||||
|
|
|
|
||
|
Sept. 30, |
|
Sept. 30, |
||
|
2024 |
|
2023 |
||
ASSETS |
|||||
Cash and cash equivalents |
$ |
20.2 |
|
$ |
38.7 |
Receivables, net |
|
126.1 |
|
|
129.3 |
Inventories, net |
|
414.1 |
|
|
399.5 |
Other current assets |
|
26.9 |
|
|
33.4 |
Property, plant and equipment, net |
|
806.5 |
|
|
852.5 |
Intangible and other noncurrent assets |
|
246.3 |
|
|
363.5 |
Total assets |
$ |
1,640.1 |
|
$ |
1,816.9 |
|
|
|
|
||
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||||
Current portion of long-term debt |
$ |
7.5 |
|
$ |
5.0 |
Other current liabilities |
|
209.5 |
|
|
269.6 |
Long-term debt, net of current portion |
|
910.0 |
|
|
800.3 |
Deferred income taxes and other noncurrent liabilities |
|
196.5 |
|
|
221.0 |
Total stockholders' equity |
|
316.6 |
|
|
521.0 |
Total liabilities and stockholders' equity |
$ | 1,640.1 |
|
$ |
1,816.9 |
COMPASS MINERALS INTERNATIONAL, INC. |
|||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
(unaudited, in millions) |
|||||||
|
Twelve Months Ended |
||||||
|
Sept. 30, |
||||||
|
|
2024 |
|
|
|
2023 |
|
Net cash provided by operating activities |
$ |
14.4 |
|
|
$ |
106.0 |
|
|
|
|
|
||||
Cash flows from investing activities: |
|
|
|
||||
Capital expenditures |
|
(114.2 |
) |
|
|
(154.3 |
) |
Acquisition of business, net of cash acquired |
|
— |
|
|
|
(18.9 |
) |
Other, net |
|
(1.9 |
) |
|
|
(4.7 |
) |
|
|
|
|
||||
Net cash used in investing activities |
|
(116.1 |
) |
|
|
(177.9 |
) |
|
|
|
|
||||
Cash flows from financing activities: |
|
|
|
||||
Proceeds from revolving credit facility borrowings |
|
422.8 |
|
|
|
150.0 |
|
Principal payments on revolving credit facility borrowings |
|
(314.2 |
) |
|
|
(220.0 |
) |
Proceeds from the issuance of long-term debt |
|
81.6 |
|
|
|
239.9 |
|
Principal payments on long-term debt |
|
(78.6 |
) |
|
|
(314.6 |
) |
Payments for contingent consideration |
|
(9.1 |
) |
|
|
— |
|
Net proceeds from private placement of common stock |
|
— |
|
|
|
240.7 |
|
Dividends paid |
|
(12.6 |
) |
|
|
(24.9 |
) |
Deferred financing costs |
|
(2.1 |
) |
|
|
(3.9 |
) |
Shares withheld to satisfy employee tax obligations |
|
(2.1 |
) |
|
|
(1.7 |
) |
Other, net |
|
(2.6 |
) |
|
|
(1.5 |
) |
|
|
|
|
||||
Net cash provided by financing activities |
|
83.1 |
|
|
|
64.0 |
|
Effect of exchange rate changes on cash and cash equivalents |
|
0.1 |
|
|
|
0.5 |
|
Net change in cash and cash equivalents |
|
(18.5 |
) |
|
|
(7.4 |
) |
Cash and cash equivalents, beginning of the year |
|
38.7 |
|
|
|
46.1 |
|
|
|
|
|
||||
Cash and cash equivalents of continuing operations, end of period |
$ |
20.2 |
|
|
$ |
38.7 |
|
COMPASS MINERALS INTERNATIONAL, INC. SEGMENT INFORMATION (unaudited, in millions) |
|||||||||||
Three Months Ended Sept. 30, 2024 |
Salt |
Plant Nutrition |
Corporate and Other(1) |
Total |
|||||||
Sales to external customers |
$ |
162.5 |
$ |
42.4 |
|
$ |
3.9 |
|
$ |
208.8 |
|
Intersegment sales |
|
— |
|
1.4 |
|
|
(1.4 |
) |
|
— |
|
Shipping and handling cost |
|
44.2 |
|
6.0 |
|
|
— |
|
|
50.2 |
|
Operating earnings (loss)(2)(3)(4) |
|
21.0 |
|
(29.7 |
) |
|
(21.1 |
) |
|
(29.8 |
) |
Depreciation, depletion and amortization |
|
16.3 |
|
8.4 |
|
|
1.9 |
|
|
26.6 |
|
Total assets |
|
1,084.5 |
|
388.1 |
|
|
167.5 |
|
|
1,640.1 |
|
|
|
|
|
|
|||||||
Three Months Ended Sept. 30, 2023 |
Salt |
Plant Nutrition |
Corporate and Other(1) |
Total |
|||||||
Sales to external customers |
$ |
186.7 |
$ |
35.3 |
|
$ |
11.6 |
|
$ |
233.6 |
|
Intersegment sales |
|
— |
|
2.6 |
|
|
(2.6 |
) |
|
— |
|
Shipping and handling cost |
|
49.6 |
|
5.0 |
|
|
0.2 |
|
|
54.8 |
|
Operating earnings (loss)(3) |
|
28.6 |
|
(3.3 |
) |
|
(23.1 |
) |
|
2.2 |
|
Depreciation, depletion and amortization |
|
15.6 |
|
8.3 |
|
|
2.0 |
|
|
25.9 |
|
Total assets |
|
1,050.4 |
|
473.4 |
|
|
293.1 |
|
|
1,816.9 |
|
|
|
|
|
|
|||||||
Twelve Months Ended Sept. 30, 2024 |
Salt |
Plant Nutrition |
Corporate and Other(1) |
Total |
|||||||
Sales to external customers |
$ |
907.8 |
$ |
181.0 |
|
$ |
28.6 |
|
$ |
1,117.4 |
|
Intersegment sales |
|
— |
|
8.0 |
|
|
(8.0 |
) |
|
— |
|
Shipping and handling cost |
|
280.1 |
|
24.6 |
|
|
0.6 |
|
|
305.3 |
|
Operating earnings (loss)(2)(3)(4) |
|
163.6 |
|
(86.4 |
) |
|
(194.0 |
) |
|
(116.8 |
) |
Depreciation, depletion and amortization |
|
63.4 |
|
34.1 |
|
|
7.5 |
|
|
105.0 |
|
|
|
|
|
|
|||||||
Twelve Months Ended Sept. 30, 2023 |
Salt |
Plant Nutrition |
Corporate and Other(1) |
Total |
|||||||
Sales to external customers |
$ |
1,010.8 |
$ |
172.1 |
|
$ |
21.8 |
|
$ |
1,204.7 |
|
Intersegment sales |
|
— |
|
9.7 |
|
|
(9.7 |
) |
|
— |
|
Shipping and handling cost |
|
324.5 |
|
21.4 |
|
|
0.2 |
|
|
346.1 |
|
Operating earnings (loss)(3)(4) |
|
170.5 |
|
9.5 |
|
|
(102.6 |
) |
|
77.4 |
|
Depreciation, depletion and amortization |
|
58.5 |
|
32.9 |
|
|
7.2 |
|
|
98.6 |
(1) |
Corporate and Other includes corporate entities, records management operations, the Fortress fire retardant business, equity method investments, lithium costs and other incidental operations and eliminations. Operating earnings (loss) for corporate and other includes indirect corporate overhead, including costs for general corporate governance and oversight, lithium-related expenses, as well as costs for the human resources, information technology, legal and finance functions. |
(2) |
The company recognized impairments of water rights for the three months ended Sept. 30, 2024. The company also recognized impairments of long-lived assets related to the termination of the lithium development project; goodwill, long-lived assets and inventory related to Fortress; and goodwill related to Plant Nutrition for the twelve months ended Sept. 30, 2024. |
(3) |
Corporate operating results were impacted by net (gain) loss of |
(4) |
The Company continued to take steps to align its cost structure to its current business needs. These initiatives impacted Corporate operating results and resulted in net severance and related charges for reductions in workforce and changes to executive leadership and additional restructuring costs related to the termination of the Company’s lithium development project of |
View source version on businesswire.com: https://www.businesswire.com/news/home/20241216999819/en/
Investor Contact
Brent Collins
Vice President, Treasurer & Investor Relations
+1.913.344.9111
InvestorRelations@compassminerals.com
Media Contact
Rick Axthelm
Chief Public Affairs and Sustainability Officer
+1.913.344.9198
MediaRelations@compassminerals.com
Source: Compass Minerals